Signaling pathways modulated by fish oil in salt-sensitive hypertension

American Journal of Physiology - Renal Physiology

Volumn 294, Issue 6, 2008, Pages

  Diaz Encarnacion, Montserrat M ^a   Warner, Gina M ^a   Gray, Catherine E ^a   Cheng, Jingfei ^a   Keryakos, Hesham K H ^a   Nath, Karl A ^a   Grande, Joseph P ^a  

^a Mayo Clinic   (United States)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Fibrosis; Glomerulosclerosis; Rat

Indexed keywords

CYCLOOXYGENASE 2; FISH OIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; CORN OIL; NEUTROPHIL CYTOSOL FACTOR 67K; NEUTROPHIL CYTOSOLIC FACTOR 1; PHOSPHOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; INFLAMMATION; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; SIGNAL TRANSDUCTION; ANIMAL; BLOOD PRESSURE; CELL DIVISION; DAHL SALT SENSITIVE RAT; DRUG EFFECT; FAT INTAKE; FIBROSIS; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; HEART MUSCLE; KIDNEY TUBULE; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; PROTEINURIA;

ANIMALS; BLOOD PRESSURE; CELL DIVISION; CORN OIL; DIETARY FATS; EPITHELIAL CELLS; FIBROSIS; FISH OILS; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HYPERTENSION, RENAL; KIDNEY TUBULES; MALE; MYOCARDIUM; NADPH OXIDASE; NF-KAPPA B; ORGAN SIZE; PHOSPHOPROTEINS; PROTEINURIA; RATS; RATS, INBRED DAHL; SIGNAL TRANSDUCTION;

EID: 48249088082     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00401.2007     Document Type: Article

References (107)

1. Abraham N, Lutton J, Drummond G, Kappas A. The biological significance and physiological role of heme oxygenase. Cell Physiol Biochem 6: 129-168, 1996.
2. Adam O. Dietary fatty acids and immune reactions in synovial tissue. Eur J Med Res 8: 381-387, 2003.
3. Adler S, Huang H. Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol 287: F907-F913, 2004.
4. Agarwal A, Balla J, Alam J, Croatt AJ, Nath KA. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48: 1298-1307, 1995.
5. Agarwal A, Nick HS. Renal response to tissue injury: lessons from heme oxygenase-1 GeneAblation and expression. J Am Soc Nephrol 11: 965-973, 2000.
6. Aguila MB, Pinheiro AR, Aquino JC, Gomes AP, Mandarimde-Lacerda CA. Different edible oil beneficial effects (canola oil, fish oil, palm oil, olive oil, and soybean oil) on spontaneously hypertensive rat glomerular enlargement and glomeruli number. Prostaglandins Other Lipid Mediat 76: 74-85, 2005.
7. Atarashi K, Ishiyama A, Takagi M, Minami M, Kimura K, Goto A, Omata M. Vitamin E ameliorates the renal injury of Dahl salt-sensitive rats. Am J Hypertens 10: 116S-119S, 1997.
8. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189: 19-30, 2006.
9. Bayorh MA, Ganafa AA, Socci RR, Silvestrov N, Abukhalaf IK. The role of oxidative stress in salt-induced hypertension. Am J Hypertens 17: 31-36, 2004.
10. Bonaa KH, Bjerve KS, Straume B, Gram IT, Thelle D. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromso study. N Engl J Med 322: 795-801, 1990.
11. Bousserouel S, Brouillet A, Bereziat G, Raymondjean M, Andreani M. Different effects of n-6 and n-3 polyunsaturated fatty acids on the activation of rat smooth muscle cells by interleukin-1 beta. J Lipid Res 44: 601-611, 2003.
12. Breslow JL. n-3 Fatty acids and cardiovascular disease. Am J Clin Nutr 83: 1477S-1482S, 2006.
13. Calder PC. n-3 Polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 41: 203-234, 1997.
14. Chen ZY, Istfan NW. Docosahexaenoic acid, a major constituent of fish oil diets, prevents activation of cyclin-dependent kinases and S-phase entry by serum stimulation in HT-29 cells. Prostaglandins Leukot Essent Fatty Acids 64: 67-73, 2001.
15. 2+ releasing agent in kidney. J Am Soc Nephrol 12: 54-60, 2001.
16. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 161: 1207-1216, 2001.
17. Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 98: 27i-33i, 2006.
18. de La Puerta Vazquez R, Martinez-Dominguez E, Sanchez Perona J, Ruiz-Gutierrez V. Effects of different dietary oils on inflammatory mediator generation and fatty acid composition in rat neutrophils. Metabolism 53: 59-65, 2004.
19. Diaz Encarnacion M, Griffin M, Slezak J, Bergstralh E, Stegall M, Velosa J, Grande J. Correlation of quantitative digital image analysis with glomerular filtration rate in CAN. Am J Transplant 4: 248-256, 2004.
20. Diep QN, Amiri F, Touyz RM, Cohn JS, Endemann D, Neves MF, Schiffrin EL. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 40: 866-871, 2002.
21. Donadio J, Grande J, Bergstralh E, Dart R, Larson T, Spencer D. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. J Am Soc Nephrol 10: 1772-1777, 1999.
22. Donadio JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. N Engl J Med 331: 1194-1199, 1994.
23. Donadio JV, Grande JP. The role of fish oil/omega-3 fatty acids in the treatment of IgA nephropathy. Semin Nephrol 24: 225-243, 2004.
24. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320: 265-271, 1989.
25. Engler MB, Engler MM. Docosahexaenoic acid-induced vasorelaxation in hypertensive rats: mechanisms of action. Biol Res Nurs 2: 85-95, 2000.
26. Engler MB, Engler MM, Browne A, Sun YP, Sievers R. Mechanisms of vasorelaxation induced by eicosapentaenoic acid (20:5n-3) in WKY rat aorta. Br J Pharmacol 131: 1793-1799, 2000.
27. Engler MB, Engler MM, Ursell PC. Vasorelaxant properties of n-3 polyunsaturated fatty acids in aortas from spontaneously hypertensive and normotensive rats. J Cardiovasc Risk 1: 75-80, 1994.
28. Forde P, Scribner AW, Dial R, Loscalzo J, Trolliet MR. Prevention of hypertension and renal dysfunction in Dahl rats by alpha-tocopherol. J Cardiovasc Pharmacol 42: 82-88, 2003.
29. Frenoux JM, Prost ED, Belleville JL, Prost JL. A polyunsaturated fatty acid diet lowers blood pressure and improves antioxidant status in spontaneously hypertensive rats. J Nutr 131: 39-45, 2001.
30. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20: 1493-1499, 2002.
31. Goumenos DS, Tsamandas AC, Oldroyd S, Sotsiou F, Tsakas S, Petropoulou C, Bonikos D, El Nahas AM, Vlachojannis JG. Transforming growth factor-1 and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease. Nephron 87: 240-248, 2001.
32. Grande J, Walker H, Holub B, Warner G, Keller D, Haugen J, Donadio J, Dousa T. Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Kidney Int 57: 1027-1040, 2000.
33. Grande JP, Donadio JV. Dietary fish oil supplementation in IgA nephropathy: a therapy in search of a mechanism? Nutrition 14: 240-242, 1998.
34. Grande JP, Donadio JV. Role of dietary fish oil supplementation in IgA nephropathy. Mechanistic implications. Minerva Urol Nefrol 53: 201-209, 2001.
35. Gu JW, Tian N, Shparago M, Tan W, Bailey AP, Manning RD Jr. Renal NF-κB activation and TNF-α upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 291: R1817-R1824, 2006.
36. Hagiwara S, Makita Y, Gu L, Tanimoto M, Zhang M, Nakamura S, Kaneko S, Itoh T, Gohda T, Horikoshi S, Tomino Y. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation. Nephrol Dial Transplant 21: 605-615, 2006.
37. Hamaguchi A, Kim S, Izumi Y, Iwao H. Chronic activation of glomerular mitogen-activated protein kinases in Dahl salt-sensitive rats. J Am Soc Nephrol 11: 39-46, 2000.
38. Harper CR, Jacobson TA. The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 161: 2185-2192, 2001.
39. Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65: 1645S-1654S, 1997.
40. Heitzer T, Wenzel U, Hink U, Krollner D, Skatchkov M, Stahl RA, MacHarzina R, Brasen JH, Meinertz T, Munzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int 55: 252-260, 1999.
41. Helton WS, Espat NJ. Defining mechanisms of -3 fatty-acid activity. Nutrition 17: 674, 2001.
42. Hermann M, Shaw S, Kiss E, Camici G, Buhler N, Chenevard R, Luscher TF, Grone HJ, Ruschitzka F. Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension. Hypertension 45: 193-197, 2005.
43. Hisaki R, Fujita H, Saito F, Kushiro T. Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats. Am J Hypertens 18: 707-713, 2005.
44. Hobbs LM, Rayner TE, Howe PR. Dietary fish oil prevents the development of renal damage in salt-loaded stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 23: 508-513, 1996.
45. Iwai J. Dahl salt-sensitive and salt-resistant rats. Hypertension 1987: I18-I20, 1987.
46. Jia Q, Zhou HR, Shi Y, Pestka JJ. Docosahexaenoic acid consumption inhibits deoxynivalenol-induced CREB/ATF1 activation and IL-6 gene transcription in mouse macrophages. J Nutr 136: 366-372, 2006.
47. Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, Lan HY. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis 38: 761-769, 2001.
48. Khalfoun B, Thibault F, Watier H, Bardos P, Lebranchu Y. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6. Adv Exp Med Biol 400B: 589-597, 1997.
49. Kielar ML, Jeyarajah DR, Penfield JG, Lu CY. Docosahexaenoic acid decreases IRF-1 mRNA and thus inhibits activation of both the IRF-E and NFkappa d response elements of the iNOS promoter. Transplantation 69: 2131-2137, 2000.
50. Kimura S, Minami M, Saito H, Kobayashi T, Okuyama H. Dietary docosahexaenoic acid (22:6n-3) prevents the development of hypertension in SHRSP. Clin Exp Pharmacol Physiol 22, Suppl 1: S308-S309, 1995.
51. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106: 2747-2757, 2002.
52. Kushiro T, Fujita H, Hisaki R, Asai T, Ichiyama I, Kitahara Y, Koike M, Sugiura H, Saito F, Otsuka Y, Kanmatsuse K. Oxidative stress in the Dahl salt-sensitive hypertensive rat. Clin Exp Hypertens 27: 9-15, 2005.
53. phox in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40: 511-515, 2002.
54. Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int 67: 867-874, 2005.
55. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004.
56. Lo CJ, Chiu KC, Fu M, Chu A, Helton S. Fish oil modulates macrophage P44/P42 mitogen-activated protein kinase activity induced by lipopolysaccharide. JPEN J Parenter Enteral Nutr 24: 159-163, 2000.
57. Lopez-Franco O, Suzuki Y, Sanjuan G, Blanco J, Hernandez-Vargas P, Yo Y, Kopp J, Egido J, Gomez-Guerrero C. Nuclear factor-κB inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol 161: 1497-1505, 2002.
58. Lowry O, Rosebrough A, Farr A, Randall R. Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275, 1951.
59. Lungershausen YK, Abbey M, Nestel PJ, Howe PR. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertens 12: 1041-1045, 1994.
60. Massaro M, Habib A, Lubrano L, Turco SD, Lazzerini G, Bourcier T, Weksler BB, De Caterina R. The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci USA 103: 15184-15189, 2006.
61. Mattson DL, James L, Berdan EA, Meister CJ. Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 48: 149-156, 2006.
62. Medeiros FJ, Aguila MB, Mandarim-de-Lacerda CA. Renal cortex remodeling in streptozotocin-induced diabetic spontaneously hypertensive rats treated with olive oil, palm oil and fish oil from Menhaden. Prostaglandins Leukot Essent Fatty Acids 75: 357-365, 2006.
63. Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41: 1346-1352, 2003.
64. Meng S, Roberts LJ 2nd, Cason GW, Curry TS, Manning RD Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 283: R732-R738, 2002.
65. Mori TA. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol 33: 842-846, 2006.
66. Mori TA, Watts GF, Burke V, Hilme E, Puddey IB, Beilin LJ. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 102: 1264-1269, 2000.
67. Mori TA, Woodman RJ. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 9: 95-104, 2006.
68. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, Kimura G. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 350: 1734-1737, 1997.
69. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88: 523-533, 1993.
70. Nath K, Grande J, Croatt A, Likely S, Hebbel R, Enright H. Intracellular targets in heme protein induced renal injury. Kidney Int 53: 100-111, 1998.
71. Nath K, Haggard J, Croatt A, Grande J, Poss K, Alam J. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol 156: 1527-1535, 2000.
72. Nath K, Vercellotti G, Grande J, Miyoshi H, Paya C, Manivel J, Haggard J, Croatt A, Payne W, Alam J. Heme protein-induced chronic renal inflammation: suppressive effect of induced heme oxygenase-1. Kidney Int 59: 106-117, 2001.
73. Nath KA. The functional significance of induction of heme oxygenase by oxidant stress. J Lab Clin Med 123: 461-463, 1994.
74. Nielsen GL, Faarvang KL, Thomsen BS, Teglbjaerg KL, Jensen LT, Hansen TM, Lervang HH, Schmidt EB, Dyerberg J, Ernst E. The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. Eur J Clin Invest 22: 687-691, 1992.
75. Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, Fukunaga M, Tamaki T, Kiyomoto H, Kohno M, Shokoji T, Kimura S, Abe Y. The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. J Am Soc Nephrol 15: 306-315, 2004.
76. 1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int 65: 972-981, 2004.
77. Nordoy A, Marchioli R, Arnesen H, Videbaek J. n-3 Polyunsaturated fatty acids and cardiovascular diseases. Lipids 36: S127-S129, 2001.
78. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ. NF-κB inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription. Am J Physiol Lung Cell Mol Physiol 284: L84-L89, 2003.
79. O'Donnell MP, Kasiske BL, Katz SA, Schmitz PG, Keane WF. Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats. Hypertension 20: 651-658, 1992.
80. Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol 10: 1-17, 1996.
81. Pownall HJ, Brauchi D, Kilinc C, Osmundsen K, Pao Q, Payton-Ross C, Gotto AM Jr, Ballantyne CM. Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis 143: 285-297, 1999.
82. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26: 137-143, 1984.
83. Rangan GK, Wang Y, Tay YC, Harris DC. Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats. Kidney Int 56: 118-134, 1999.
84. Rapp J. Dahl salt-susceptible and salt-resistant rats. A review. Hypertension 4: 753-763, 1982.
85. Rapp JP, Dene H. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 7: 340-349, 1985.
86. Rayner TE, Howe PR. Purified omega-3 fatty acids retard the development of proteinuria in salt-loaded hypertensive rats. J Hypertens 13: 771-780, 1995.
87. Reddi AS, Nimmagadda VR, Arora R. Effect of antihypertensive therapy on renal artery structure in type 2 diabetic rats with hypertension. Hypertension 37: 1273-1278, 2001.
88. Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 43: 142-146, 2004.
89. Schneider SM, Fung VS, Palmblad J, Babior BM. Activity of the leukocyte NADPH oxidase in whole neutrophils and cell-free neutrophil preparations stimulated with long-chain polyunsaturated fatty acids. Inflammation 25: 17-23, 2001.
90. Shimamura T, Wilson AC. Influence of dietary fish oil on the aortic, myocardial, and renal lesions of SHR. J Nutr Sci Vitaminol (Tokyo) 37: 581-590, 1991.
91. Stone NJ. Fish consumption, fish oil, lipids, and coronary heart disease. Circulation 94: 2337-2340, 1996.
92. Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long-term issues. Hypertension 17: I61-I68, 1991.
93. Takizawa T, Takasaki I, Shionoiri H, Ishii M. Progression of glomerulosclerosis, renal hypertrophy, and an increased expression of fibronectin in the renal cortex associated with aging and salt-induced hypertension in Dahl salt-sensitive rats. Life Sci 61: 1553-1558, 1997.
94. Terano T, Tanaka T, Tamura Y, Kitagawa M, Higashi H, Saito Y, Hirai A. Eicosapentaenoic acid and docosahexaenoic acid inhibit vascular smooth muscle cell proliferation by inhibiting phosphorylation of Cdk2-cyclinE complex. Biochem Biophys Res Commun 254: 502-506, 1999.
95. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD Jr. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 45: 934-939, 2005.
96. Tomoda F, Takata M, Kinuno H, Tomita S, Yasumoto K, Inoue H. Renal structural properties in prehypertensive Dahl salt-sensitive rats. Hypertension 36: 68-72, 2000.
97. USRDS. Atlas of end-stage renal disease in the United States. In: 2001 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2001.
98. Vaskonen T, Laakso J, Mervaala E, Sievi E, Karppanen H. Interrelationships between salt and fish oil in stroke-prone spontaneously hypertensive rat. Blood Press 5: 178-189, 1996.
99. Wang HH, Hung TM, Wei J, Chiang AN. Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice. Cardiovasc Res 61: 169-176, 2004.
100. Wang PX, Sanders PW. Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: a primary disorder of vascular smooth muscle. Am J Physiol Renal Physiol 288: F236-F242, 2005.
101. Watanabe S, Katagiri K, Onozaki K, Hata N, Misawa Y, Hamazaki T, Okuyama H. Dietary docosahexaenoic acid but not eicosapentaenoic acid suppresses lipopolysaccharide-induced interleukin-1 beta mRNA induction in mouse spleen leukocytes. Prostaglandins Leukot Essent Fatty Acids 62: 147-152, 2000.
102. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 27: 481-490, 1996.
103. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159: 1465-1475, 2001.
104. Yin K, Chu ZM, Beilin LJ. Effect of fish oil feeding on blood pressure and vascular reactivity in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 17: 235-239, 1990.
105. Ying WZ, Sanders PW. Enhanced expression of EGF receptor in a model of salt-sensitive hypertension. Am J Physiol Renal Physiol 289: F314-F321, 2005.
106. Yusufi A, Cheng J, Thompson M, Walker H, Gray C, Warner G, Grande J. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells. J Lab Clin Med 141: 318-329, 2003.
107. Zhao Y, Joshi-Barve S, Barve S, Chen LH. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappaB activation. J Am Coll Nutr 23: 71-78, 2004.